Home600645 • SHA
add
Vcanbio Cell & Gene Engineering Corp Ltd
Nakaraang pagsara
¥27.81
Sakop ng araw
¥27.61 - ¥29.06
Sakop ng taon
¥18.45 - ¥30.32
Market cap
13.29B CNY
Average na Volume
13.77M
P/E ratio
174.94
Dividend yield
-
Primary exchange
SHA
Mga balita tungkol sa merkado
Bloomberg.com
40 minuto ang nakalipas
Japanese Stocks Rally, Bond Sale Sees Solid Demand: Markets Wrap
1.82%
0.30%
0.86%
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 376.09M | -6.82% |
Gastos sa pagpapatakbo | 208.78M | -10.39% |
Net na kita | 50.14M | 3.74% |
Net profit margin | 13.33 | 11.36% |
Kita sa bawat share | — | — |
EBITDA | 87.52M | -6.41% |
Aktuwal na % ng binabayarang buwis | 25.83% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.66B | 15.64% |
Kabuuang asset | 5.32B | 0.70% |
Kabuuang sagutin | 1.56B | -2.80% |
Kabuuang equity | 3.76B | — |
Natitirang share | 455.90M | — |
Presyo para makapag-book | 3.42 | — |
Return on assets | 2.93% | — |
Return on capital | 4.06% | — |
Cash Flow
Net change in cash
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 50.14M | 3.74% |
Cash mula sa mga operasyon | 99.82M | 26.82% |
Cash mula sa pag-invest | 58.56M | 602.91% |
Cash mula sa financing | -25.16M | 66.90% |
Net change in cash | 131.45M | 977.46% |
Malayang cash flow | -35.99M | 48.84% |
Tungkol
Itinatag
1992
Website
Mga Empleyado
2,014
